期刊文献+

56例川崎病患儿临床表现及心血管系统损害分析 被引量:4

Clinical manifestations and cardiovascular damages of 56 cases of childhood Kawasaki disease
暂未订购
导出
摘要 目的分析川崎病住院患儿的临床表现及辅助检查相关指标与心血管系统的并发症之间的关系,为川崎病的治疗提供指导。方法 2008年1月至2013年1月温岭市妇女儿童医院儿科收住的川崎病患儿56例为研究对象,入院后收集患儿的临床资料,查体并行相关辅助检查,对上述指标进行统计学分析。结果①56例川崎病患儿合并心血管系统损害的有34例,占总人数的60.71%。其中心电图异常12例(21.43%),心脏彩超异常31例(55.36%),两者均异常者9例;②多因素Logistic回归分析提示:C-反应蛋白(CRP)OR=1.786,就诊前发热持续时间(OR=1.345),血小板计数(PLT)OR=2.565,与川崎病患儿心血管系统损害均有显著意义(均P<0.05)。结论川崎病患儿早期发生心血管系统损害的比率高,CRP、就诊前发热持续时间和PLT是心血管系统损害的高危因素,在发病早期应以上因素高度重视。 Objective To investigate the clinical manifestations of hospitalized children with Kawasaki disease and the correlation between indexes of auxiliary examination and the complications of cardiovascular system, so as to provide some guidance for treatment of the disease.Methods The study included 56 children with Kawasaki disease hospitalized in pediatric department of Wenling Women and Children’ s Hospital during the period of January 2008 to January 2013.The clinical data of the children were collected.They took physical examination and some auxiliary examinations.All of the indexes were analyzed statistically.Results Totally 34 of 56 cases of Kawasaki disease were complicated with cardiovascular damages, accounting for 60.71%.There were 12 cases (21.43%) with abnormal ECG and 31 cases with abnormal cardiac ultrasonic results (55.36%).Nine cases suffered both.Multivariate Logistic regression analysis showed that CRP (OR=1.786), duration of fever before treatment (OR=1.345) and PLT (OR=2.565) were significantly correlated with cardiovascular damages in children with Kawasaki disease (all P〈0.05).Conclusion The incidence of cardiovascular damages on children with Kawasaki disease at early stage is high.CRP, heating duration before treatment and PLT are high-risk factors of cardiovascular damages, therefore, much attention should be paid to the above factors at early stage.
出处 《中国妇幼健康研究》 2015年第2期280-281,309,共3页 Chinese Journal of Woman and Child Health Research
关键词 儿童 川崎病 临床表现 心血管病变 并发症 children Kawasaki disease clinical manifestations cardiovascular disease complication
  • 相关文献

参考文献7

二级参考文献47

共引文献306

同被引文献25

  • 1Suzuki H, Terai M, Hamada H, et al. Cyclosporin a treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin[J]. Pediatr Infect Dis J,2011,30 (10) :871-876.
  • 2Moil M, Imagawa T, Hara R, et al. Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series[J]. J Rheumatol,2012,39(4) :864-867.
  • 3Rigante D, Valentini P, Rizzo D, et al. Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single -center cohort of Italian patients with Kawasaki syndrome [J]. Rheumatol Int. 2010, 30 ( 6 ): 841-846.
  • 4KuoH C, Yang K D, Chang W C, et al. Kawasaki disease: an update on diagnosis and treatment[J]. Pediatr Neonatol, 2012,53 (1) :4-11.
  • 5Tremoulet A H, Pancoast P, Franco A, et al. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease [J]. J Pediatr,2012,161(3) :506-512.
  • 6Kim J O, Kim Y H, Hyun M C. Comparison between Kawasaki disease with lymph-node-first presentation and Kawasaki disease without cervical lymphadenopathy [J]. Korean J Pediatr, 2016,59 (2) :54-58.
  • 7Hoyos-Bachiloglu R, Garc~a A, Morales P S, et al. Geographic distribution of Kawasaki disease throughout Chile[J]. Rev Chilena lnfecto1,2016,33 ( 1 ) : 12-18.
  • 8丁粤粤,徐秋琴,任彦,孙凌,张建敏,吕海涛,严文华.超声评价急性期川崎病合并冠状动脉非扩张性损害的左前降支血流动力学变化[J].中国医学影像技术,2011,27(3):529-532. 被引量:5
  • 9姜毅,李温慈,徐海滨,邵山鹰.川崎病患儿血清胱抑素C的变化及其与冠状动脉病变的关系[J].新医学,2011,42(10):638-639. 被引量:6
  • 10谢利剑,黄敏.川崎病冠状动脉损害的远期治疗与随访管理[J].实用儿科临床杂志,2011,26(21):1623-1625. 被引量:5

引证文献4

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部